Yazar "Sendur, Mehmet Ali Nahit" için listeleme
-
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
Aydın, Dinçer; Sendur, Mehmet Ali Nahit; Kefeli, Umut; Ünal, Olcun Umit; Tastekin, Didem; Akyol, Murat; Gümüş, Mahmut; Yetişyiğit, Tarkan (Cig Media Group, Lp, 2017)This is a multicenter study to assess the prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma (SBA). A total of 78 patients with SBA diagnosed with completely resected SBA were involved ... -
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Hizal, Mutlu; Bilgin, Burak; Paksoy, Nail; Acıkgöz, Özgür; Sezer, Ahmet; Gürbüz, Mustafa; Sendur, Mehmet Ali Nahit; İriağaç, Yakup (Springer, 2021)Introduction Osimertinib, an irreversible third-generation EGFR-TKI, is the standard of care for second-line treatment of T790M-mutant advanced NSCLC patients whose disease progressed after first-line EGFR-TKI therapy. In ...